EXBLIFEP

This brand name is authorized in Lithuania, United States

Active ingredients

The drug EXBLIFEP contains a combination of these active pharmaceutical ingredients (APIs):

1 Cefepime UNII 807PW4VQE3 - CEFEPIME

Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases. Read about Cefepime

2 Enmetazobactam UNII 80VUN7L00C - ENMETAZOBACTAM

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EXBLIFEP Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR
EXBLIFEP Powder for concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DE51		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1099361
Country: US	FDA, National Drug Code	Identifier(s): 83289-101